Table 1.
Demographic data and endoscopic findings of 257 patients with H pylori infection who were randomly assigned to standard triple therapy (group A) or triple therapy plus ecabet sodium (group B)
| Group A | Group B | P value | |
| Patients | 129 | 128 | |
| Age (yr) (mean ± SD) | 54.3 ± 13.2 | 53.4 ± 12.4 | 0.562 |
| Gender (male/female) | 68/61 | 80/48 | 0.112 |
| BMI (kg/m2) (mean ± SD) | 23.3 ± 2.9 | 23.2 ± 3.0 | 0.768 |
| Smoking | 32 (24.8%) | 32 (25.0%) | 0.971 |
| Alcohol consumption | 40 (31.0%) | 56 (43.8%) | 0.035 |
| Endoscopic findings | 0.333 | ||
| Gastric ulcer | 62 | 66 | |
| Duodenal ulcer | 37 | 26 | |
| Gastroduodenal ulcer | 8 | 6 | |
| Gastric cancer1 | 7 | 5 | |
| Gastric MALT lymphoma | 0 | 1 | |
| Gastritis | 15 | 24 |
1
Patients who had received endoscopic treatment for early gastric cancer or adenoma.